Abstract
BackgroundSwietenia macrophylla King (Meliaceae) is used to treat diabetes mellitus in Malaysia. This study aims to evaluate the anti-hyperglycaemic potential of petroleum ether (PE), chloroform (CE) and methanol (ME) extracts of S. macrophylla seeds, in normoglycaemic and streptozotocin (STZ)-induced diabetic rats.MethodsFollowing treatment of normoglycaemic rats with S. macrophylla seed extracts, hypoglycaemic and intraperitoneal glucose tolerance tests (IPGTT) were performed, and blood glucose concentrations were measured. Similarly, glucose concentrations were measured after 1 and 14 days of extract treatment of STZ-induced diabetic rats. Glucose absorption by isolated everted intestine and glucose uptake by isolated abdominal muscle were tested after treatment with seed extracts. Gas chromatography mass spectrometry (GC-MS) analysis was performed on PE of S. macrophylla seeds to identify the compounds responsible for its activity.ResultsNone of the extracts had a significant effect on the blood glucose levels of 60 randomly selected normoglycaemic (normal) and diabetic rats undergoing hypoglycaemic tests. PE, however, significantly reduced blood glucose levels in 30 randomly selected normoglycaemic rats undergoing IPGTT tests 30–120 minutes after glucose administration. Repeated doses of 1000 mg/kg and 500 mg/kg PE to STZ-induced diabetic rats for 14 days did not reduce blood glucose levels significantly. PE did not significantly reduced the intestinal absorption of glucose, but significantly increased glucose uptake by abdominal muscle in the absence or presence of insulin. GC-MS analysis indicated that diterpenes, triterpenoids, fatty acid methyl esters, aldehydes and phytosterols may be responsible for the glucose lowering effects of PE.ConclusionPE extracts of S. macrophylla seeds showed anti-hyperglycaemic activity on IPGTTs . GC-MS analysis on the PE revealed that several compounds, including fucosterol and β-sitosterol, may be responsible for these anti-hyperglycaemic properties.
Highlights
Swietenia macrophylla King (Meliaceae) is used to treat diabetes mellitus in Malaysia
Diabetes mellitus is a disease in which the homeostasis of carbohydrate, protein and lipid metabolism is improperly regulated by insulin, resulting in elevated fasting and post-prandial blood glucose concentrations
Hypoglycaemic test in normal rats Oral administration of 1000 mg/kg of the three S. macrophylla seed extracts to normal rats, had no effect on fasting blood glucose concentrations, compared with control rats, whereas the positive control, 10 mg/kg glibenclamide, significantly reduced fasting blood glucose concentrations (Figure 1)
Summary
Swietenia macrophylla King (Meliaceae) is used to treat diabetes mellitus in Malaysia. Chronic hyperglycaemia causes many complications, including nephropathy, retinopathy, neuropathy, and macrovascular and microvascular damage [1]. Polydipsia, polyphagia, weight loss, fatigue, cramps, constipation and blurred vision. Patients with diabetes mellitus are treated with oral hypoglycaemic agents (OHA) and insulin [4]. These drugs, are not suitable for use during pregnancy and can produce serious side effects [5,6,7,8]. The use of medicinal plants to treat diabetes mellitus is popular, as herbal drugs are generally regarded as free of toxic effects [9]. The search for more effective and safer herbal anti-diabetic agents has become an area of active research
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
